Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 131

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

DNA Damage in Oocytes Induces a Switch of the Quality Control Factor TAp63α from Dimer to Tetramer

Deutsch, Gregor B., Zielonka, Elisabeth M., Coutandin, Daniel, Weber, Tobias A., Schäfer, Birgit, Hannewald, Jens, Luh, Laura M., Durst, Florian G., Ibrahim, Mohamed, Hoffmann, Jan, Niesen, Frank H., Sentürk, Aycan, Kunkel, Hana, Brutschy, Bernd, Schleiff, Enrico, Knapp, Stefan, Acker-Palmer, Amparo, Grez, Manuel, McKeon, Frank, Dötsch, Volker·2011·Cell

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2011.01.013

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract
Graphical abstract CC BY · PubMed Central
Figure 1 TAp63α Is Kept in an Inactive Dimeric State (A) Comparison of the domain structure of p53, TAp63α, TAp63γ, and ΔNp63α showing the transactivation (TA) domain, DNA binding domain (DBD), oligomerization domain (OD), sterile α-motive (SAM) domain, and transactivation inhibitory (TI) domain. (B) SEC chromatogram of TAp63α (green), MBP-TAp63α (black), MBP-TAp63αFTL (red), and MBP-TAp63γ (blue) purified from E. coli. Apparent molecular weights are indicated. Void volume and elution volumes of globular standard proteins with corresponding molecular weights are shown on the x axis. (C) Bar diagram showing relative accessibilities of cysteines in MBP-TAp63α (black) and MBP-TAp63αFTL (red) as monitored by binding of a maleimide-biotin conjugate. The value of MBP-TAp63α is set to 100%. Error bars show standard deviation. (D–G) Change of differential refractive index (dRI, solid line) and of the molecular weight of the protein peak (MW, dotted line) in SEC-MALS analysis of MBP-TAp63α (D), TAp63α (E), MBP-TAp63αFTL, (F) and MBP-TAp63γ (G). Calculated molecular weights are displayed. See also Figure S1 and Table S1.
Figure 1 TAp63α Is Kept in an Inactive Dimeric State (A) Comparison of the domain structure of p53, TAp63α, TAp63γ, and ΔNp63α showing the transactivation (TA) domain, DNA binding domain (DBD), oligomerization domain (OD), sterile α-motive (SAM) domain, and transactivation inhibitory (TI) domain. (B) SEC chromatogram of TAp63α (green), MBP-TAp63α (black), MBP-TAp63αFTL (red), and MBP-TAp63γ (blue) purified from E. coli. Apparent molecular weights are indicated. Void volume and elution volumes of globular standard proteins with corresponding molecular weights are shown on the x axis. (C) Bar diagram showing relative accessibilities of cysteines in MBP-TAp63α (black) and MBP-TAp63αFTL (red) as monitored by binding of a maleimide-biotin conjugate. The value of MBP-TAp63α is set to 100%. Error bars show standard deviation. (D–G) Change of differential refractive index (dRI, solid line) and of the molecular weight of the protein peak (MW, dotted line) in SEC-MALS analysis of MBP-TAp63α (D), TAp63α (E), MBP-TAp63αFTL, (F) and MBP-TAp63γ (G). Calculated molecular weights are displayed. See also Figure S1 and Table S1.CC BY · PubMed Central
Figure 2 Activation of TAp63α by Phosphorylation in Oocytes Leads to Tetramerization (A) Western blot of murine oocyte samples. p63 signals in the lysate of murine oocytes, SEC elution fractions at 1.3 ml (tetrameric protein) and 1.55 ml (dimeric protein) for both nonirradiated (NIRR) and γ-irradiated (IRR) oocytes are displayed. (B) Western blot of SEC elution fractions from 1.2 to 1.65 ml of NIRR ovary lysate. (C) Bar diagram showing relative p63 signal intensities of the western blot shown in (B). The sum of the intensities of all fractions was set to 100%. (D and E) Corresponding data and analysis for IRR ovary lysate. See also Figure S2.
Figure 2 Activation of TAp63α by Phosphorylation in Oocytes Leads to Tetramerization (A) Western blot of murine oocyte samples. p63 signals in the lysate of murine oocytes, SEC elution fractions at 1.3 ml (tetrameric protein) and 1.55 ml (dimeric protein) for both nonirradiated (NIRR) and γ-irradiated (IRR) oocytes are displayed. (B) Western blot of SEC elution fractions from 1.2 to 1.65 ml of NIRR ovary lysate. (C) Bar diagram showing relative p63 signal intensities of the western blot shown in (B). The sum of the intensities of all fractions was set to 100%. (D and E) Corresponding data and analysis for IRR ovary lysate. See also Figure S2.CC BY · PubMed Central
Figure 3 Functional Consequences of Tetramer Formation (A–C) DNA-binding of MBP-TAp63α (A), MBP-TAp63αFTL (B), and MBP-TAp63γ (C) from E. coli to the p21 response element measured by fluorescence anisotropy. Solid lines show the fit to a two-binding-site model (see Supplemental Information). Error bars show standard deviation. (D) Western blot of SEC elution fractions between 1.1 and 1.7 ml of IRR ovary lysate without λ-phosphatase treatment. (E) Bar diagram representing the relative p63 intensities of the western blot shown in (D). (F and G) Corresponding western blot and bar diagram for IRR lysate with λ-phosphatase treatment are shown in (F) and (G), respectively. (H) Bar diagram showing ratios between the sum of the signal intensities of tetramer (1.10–1.40 ml) and dimer (1.45–1.70 ml) fractions of SEC elution fractions of ovary lysate without (IRR – λPP) and with (IRR + λPP) λ-phosphatase treatment. See also Figure S3.
Figure 3 Functional Consequences of Tetramer Formation (A–C) DNA-binding of MBP-TAp63α (A), MBP-TAp63αFTL (B), and MBP-TAp63γ (C) from E. coli to the p21 response element measured by fluorescence anisotropy. Solid lines show the fit to a two-binding-site model (see Supplemental Information). Error bars show standard deviation. (D) Western blot of SEC elution fractions between 1.1 and 1.7 ml of IRR ovary lysate without λ-phosphatase treatment. (E) Bar diagram representing the relative p63 intensities of the western blot shown in (D). (F and G) Corresponding western blot and bar diagram for IRR lysate with λ-phosphatase treatment are shown in (F) and (G), respectively. (H) Bar diagram showing ratios between the sum of the signal intensities of tetramer (1.10–1.40 ml) and dimer (1.45–1.70 ml) fractions of SEC elution fractions of ovary lysate without (IRR – λPP) and with (IRR + λPP) λ-phosphatase treatment. See also Figure S3.CC BY · PubMed Central
Figure 4 The Second Helix of the TD Is Essential for Tetramer Formation (A) Western blot of SEC elution fractions between 1.05 and 1.70 ml of TAp63α expressed in rabbit reticulocyte lysate (RRL) using an anti-myc antibody. (B) Bar diagram showing the relative p63 intensities of the western blot shown in (A). Corresponding data and analysis of TAp63αFTL, TAp63αΔHelix, and TAp63αFTLΔHelix are shown in (C and D), (E and F), and (G and H), respectively. See also Figure S4.
Figure 4 The Second Helix of the TD Is Essential for Tetramer Formation (A) Western blot of SEC elution fractions between 1.05 and 1.70 ml of TAp63α expressed in rabbit reticulocyte lysate (RRL) using an anti-myc antibody. (B) Bar diagram showing the relative p63 intensities of the western blot shown in (A). Corresponding data and analysis of TAp63αFTL, TAp63αΔHelix, and TAp63αFTLΔHelix are shown in (C and D), (E and F), and (G and H), respectively. See also Figure S4.CC BY · PubMed Central
Figure 5 The TD of TAp63α Plays an Essential Role in Maintaining the Inhibited Dimeric State (A) Sequence alignment of the TDs of human p73 and murine p63. Based on the structure of human p73 the structure of murine p63 was modeled. Conserved regions are indicated by gray boxes. Amino acids that were mutated in p63 are shown in red, cyan, and orange. (B–D) Structure of the human p73 TD (PDB accession code: 2KBY). Side chains of residues that are homologous to the amino acids mutated in p63 are shown in the same colors as in (A). (B) shows mutations in TAp63αMI, (C) shows mutations in TAp63αL, and (D) shows mutations in TAp63αLM. (E) Transcriptional activities on the p21 promoter in SAOS2 cells normalized to the protein concentration of TAp63αLM, TAp63αL, TAp63αMI, TAp63α, and TAp63γ. Error bars show standard deviation. (F) Western blot of pull-down experiments with TAp63αLM, TAp63αL, TAp63αMI, TAp63α, and TAp63γ from RRL using immobilized TID. Input (IP) and pull-down (PD) are shown for each protein. (G) Bar diagram showing the quantitative analysis of the pull-down experiments in (F). Error bars show standard deviation. (H and I) Western blot (H) and corresponding bar diagram (I) showing the quantitative analysis of pull-down experiments with TAp63α, TAp63γ, TAp63αFTL, TAp63αMI, and TAp63αLM from RRL using immobilized TA domain. Error bars show standard deviation. See also Figure S5.
Figure 5 The TD of TAp63α Plays an Essential Role in Maintaining the Inhibited Dimeric State (A) Sequence alignment of the TDs of human p73 and murine p63. Based on the structure of human p73 the structure of murine p63 was modeled. Conserved regions are indicated by gray boxes. Amino acids that were mutated in p63 are shown in red, cyan, and orange. (B–D) Structure of the human p73 TD (PDB accession code: 2KBY). Side chains of residues that are homologous to the amino acids mutated in p63 are shown in the same colors as in (A). (B) shows mutations in TAp63αMI, (C) shows mutations in TAp63αL, and (D) shows mutations in TAp63αLM. (E) Transcriptional activities on the p21 promoter in SAOS2 cells normalized to the protein concentration of TAp63αLM, TAp63αL, TAp63αMI, TAp63α, and TAp63γ. Error bars show standard deviation. (F) Western blot of pull-down experiments with TAp63αLM, TAp63αL, TAp63αMI, TAp63α, and TAp63γ from RRL using immobilized TID. Input (IP) and pull-down (PD) are shown for each protein. (G) Bar diagram showing the quantitative analysis of the pull-down experiments in (F). Error bars show standard deviation. (H and I) Western blot (H) and corresponding bar diagram (I) showing the quantitative analysis of pull-down experiments with TAp63α, TAp63γ, TAp63αFTL, TAp63αMI, and TAp63αLM from RRL using immobilized TA domain. Error bars show standard deviation. See also Figure S5.CC BY · PubMed Central
Figure 6 p63 TA1 Binds to the Oligomerization Domain of p63 (A) SEC chromatogram of His-MBP-ΔNp63αPPR purified from E. coli lacking the last 25 unstructured residues. The apparent molecular weight is indicated. Void volume and elution volumes of globular standard proteins with corresponding molecular weights are shown on the x axis. (B) Chemical shift perturbations (CSPs) on p63 OD (color coded) and p63 TD (gray) after addition of p63 TA1. OD residues are colored in blue, those with CSP >0.1 ppm are shown in red and those with CSPs >0.05 ppm are shown in orange. (C and D) [15N,1H]-TROSY spectra of 15N-labeled p63 OD in presence (red) and absence (blue) of p63 TA1 (C) and of p63 TA1FWL (D). (E) Model of p63 TD based on the structure of human p73 TD. Residues are colored according to the code in (B). Helix H2 of the TD (white) lies on top of the TA1-OD interaction interface. H2 is either shown as a ribbon or as a space-filling model. (F) Sequences of p63 TA1 and p63 TA1FWL with the additional F10W mutation for UV280nm-based quantification. (G and H) Western blot (G) and corresponding bar diagram (H) of SEC elution fractions between 1.05 and 1.70 ml of TAp63αFWL expressed in RRL using an anti-myc antibody. (I and J) Western blot (I) and corresponding bar diagram (J) of pull-down experiments with TAp63αFWL and ΔNp63α from RRL using immobilized TA domain. Input (IP) and pull-down (PD) for each protein are shown in (I). For comparison, pull-down results for TAp63α and TAp63γ from Figure 5H are shown. Error bars show standard deviation.
Figure 6 p63 TA1 Binds to the Oligomerization Domain of p63 (A) SEC chromatogram of His-MBP-ΔNp63αPPR purified from E. coli lacking the last 25 unstructured residues. The apparent molecular weight is indicated. Void volume and elution volumes of globular standard proteins with corresponding molecular weights are shown on the x axis. (B) Chemical shift perturbations (CSPs) on p63 OD (color coded) and p63 TD (gray) after addition of p63 TA1. OD residues are colored in blue, those with CSP >0.1 ppm are shown in red and those with CSPs >0.05 ppm are shown in orange. (C and D) [15N,1H]-TROSY spectra of 15N-labeled p63 OD in presence (red) and absence (blue) of p63 TA1 (C) and of p63 TA1FWL (D). (E) Model of p63 TD based on the structure of human p73 TD. Residues are colored according to the code in (B). Helix H2 of the TD (white) lies on top of the TA1-OD interaction interface. H2 is either shown as a ribbon or as a space-filling model. (F) Sequences of p63 TA1 and p63 TA1FWL with the additional F10W mutation for UV280nm-based quantification. (G and H) Western blot (G) and corresponding bar diagram (H) of SEC elution fractions between 1.05 and 1.70 ml of TAp63αFWL expressed in RRL using an anti-myc antibody. (I and J) Western blot (I) and corresponding bar diagram (J) of pull-down experiments with TAp63αFWL and ΔNp63α from RRL using immobilized TA domain. Input (IP) and pull-down (PD) for each protein are shown in (I). For comparison, pull-down results for TAp63α and TAp63γ from Figure 5H are shown. Error bars show standard deviation.CC BY · PubMed Central
Figure 7 Model of the Inhibition of TAp63α (A) Schematic representation of TAp63α showing the transactivation domain (TA), tetramerization domain (TD) and transactivation inhibitory domain (TI). (B) Activation of TAp63α requires disruption of the TA-TID-TD interaction network resulting in an open conformation that enables tetramerization. Tetramers are then stabilized by helix H2 in the TD that reaches across the tetramerization interface.
Figure 7 Model of the Inhibition of TAp63α (A) Schematic representation of TAp63α showing the transactivation domain (TA), tetramerization domain (TD) and transactivation inhibitory domain (TI). (B) Activation of TAp63α requires disruption of the TA-TID-TD interaction network resulting in an open conformation that enables tetramerization. Tetramers are then stabilized by helix H2 in the TD that reaches across the tetramerization interface.CC BY · PubMed Central
Figure S1 TAp63α Forms Inactive, Closed Dimers, whereas Active Forms Are Tetrameric and Open, Related to Figure 1 (A–D) Coomassie stained SDS-PAGE analyses of MBP-TAp63α (A), TAp63α (B), MBP-TAp63αFTL (C) and MBP-TAp63γ (D) purified from E. coli cross linked with glutaraldehyde. Different concentrations of protein and different reaction times were used as indicated. Protein bands corresponding to monomeric, dimeric and higher oligomeric proteins are labeled by arrowheads, asterisks and arrows, respectively. (E) LILBID anion spectrum of MBP-TAp63α. The spectrum was recorded using a protein concentration of ∼10 μM and averaged over 200 droplets. The ruler indicates the charge distribution of a 232 kDa molecule. Laser energy was adjusted to 8mJ/pulse. Masses correspond to a dimeric protein with charges between 1 and 6. A small peak for the triple charged tetramer is seen at 155 × 103 m/z (beginning of the peak). (F) AUC sedimentation equilibrium absorbance scans (at 280 nm) of MBP-TAp63α (black), MBP-TAp63α FTL (red) and MBP-TAp63γ (blue). A protein concentration of 4 μM and a speed of 7000 rpm was used. (G and H) Species distributions of MBP-TAp63α (black) and MBP-TAp63αFTL (red), as well as of MBP-TAp63γ (blue) (H) according to their sedimentation coefficients, determined by AUC sedimentation velocity at 45,000 rpm. A protein concentration of 4 μM was used. The positions of monomers (M), dimers (D) and tetramers (T) are denoted in the graph. Additional peaks visible for MBP-TAp63αFTL and MBP-TAp63γ, as denoted by asterisks, indicate low concentration of additional species (trimer, pentamer, etc.). Comparison of the apparent sedimentation coefficient and frictional ratio of tetrameric MBP-TAp63αFTL and MBP-TAp63γ with the wild-type dimer supports an open conformation of the tetrameric form. (I) Bar diagram showing absolute signal intensities of the detection of MBP (yellow) and maleimide-biotin conjugate covalently linked to accessible cysteines (orange) of MBP-TAp63α and MBP-TAp63αFTL purified from E. coli, BSA and as negative control buffer, averaged over three experiments. Error bars show standard deviation.
Figure S1 TAp63α Forms Inactive, Closed Dimers, whereas Active Forms Are Tetrameric and Open, Related to Figure 1 (A–D) Coomassie stained SDS-PAGE analyses of MBP-TAp63α (A), TAp63α (B), MBP-TAp63αFTL (C) and MBP-TAp63γ (D) purified from E. coli cross linked with glutaraldehyde. Different concentrations of protein and different reaction times were used as indicated. Protein bands corresponding to monomeric, dimeric and higher oligomeric proteins are labeled by arrowheads, asterisks and arrows, respectively. (E) LILBID anion spectrum of MBP-TAp63α. The spectrum was recorded using a protein concentration of ∼10 μM and averaged over 200 droplets. The ruler indicates the charge distribution of a 232 kDa molecule. Laser energy was adjusted to 8mJ/pulse. Masses correspond to a dimeric protein with charges between 1 and 6. A small peak for the triple charged tetramer is seen at 155 × 103 m/z (beginning of the peak). (F) AUC sedimentation equilibrium absorbance scans (at 280 nm) of MBP-TAp63α (black), MBP-TAp63α FTL (red) and MBP-TAp63γ (blue). A protein concentration of 4 μM and a speed of 7000 rpm was used. (G and H) Species distributions of MBP-TAp63α (black) and MBP-TAp63αFTL (red), as well as of MBP-TAp63γ (blue) (H) according to their sedimentation coefficients, determined by AUC sedimentation velocity at 45,000 rpm. A protein concentration of 4 μM was used. The positions of monomers (M), dimers (D) and tetramers (T) are denoted in the graph. Additional peaks visible for MBP-TAp63αFTL and MBP-TAp63γ, as denoted by asterisks, indicate low concentration of additional species (trimer, pentamer, etc.). Comparison of the apparent sedimentation coefficient and frictional ratio of tetrameric MBP-TAp63αFTL and MBP-TAp63γ with the wild-type dimer supports an open conformation of the tetrameric form. (I) Bar diagram showing absolute signal intensities of the detection of MBP (yellow) and maleimide-biotin conjugate covalently linked to accessible cysteines (orange) of MBP-TAp63α and MBP-TAp63αFTL purified from E. coli, BSA and as negative control buffer, averaged over three experiments. Error bars show standard deviation.CC BY · PubMed Central
Figure S2 Dilution of MBP-TAp63γ Leads to a Shift of the Tetramerization Equilibrium toward Dimers, Related to Figure 2 (A) SEC chromatogram of MBP-TAp63α (black), MBP-TAp63αFTL (red), MBP-TAp63γ (blue) and TAp63α (green) purified from E. coli indicating the amount of overlap of the tetramer and dimer fractions on a Superose 6 PC 3.2/30 column. Apparent molecular weights are indicated. Void volume and elution volumes of globular standard proteins with corresponding molecular weights are shown on the x axis. The chromatogram reveals that p63 forms show the same relative elution profiles on a Superose 6 PC 3.2/30 column as on a Superose 6 10/300 GL column (results shown in Figure 5B). Deviations in the predicted masses of the peaks between both columns are due to the lower resolution of the Superose 6 PC 3.2/30 column. (B and C) Bar diagrams showing the intensities of TAp63α (B) and MBP-TAp63γ (C) relative to the respective total intensity for the SEC chromatogram shown in (A). Each value represents a 50 μl fraction between 1.2 and 1.65 ml elution volume. The diagram in (B) displays a maximum at ∼1.55 ml (dimer fraction) and the diagram in (C) at ∼1.35 ml (tetramer fraction) elution volume. The concentration of both proteins was approximately 5 μM. (D) Western blot of 50 μl SEC elution fractions between 1.2 and 1.65 ml of 100 nM MBP-TAp63γ purified from E. coli. (E) Bar diagrams showing the MBP-TAp63γ signal intensities relative to the sum of all intensities of the Western blot in (D). (F and G) Western blot of 50 μl SEC elution fractions between 1.2 and 1.65 ml of 30 nM MBP-TAp63γ (F) and corresponding bar diagram (G).
Figure S2 Dilution of MBP-TAp63γ Leads to a Shift of the Tetramerization Equilibrium toward Dimers, Related to Figure 2 (A) SEC chromatogram of MBP-TAp63α (black), MBP-TAp63αFTL (red), MBP-TAp63γ (blue) and TAp63α (green) purified from E. coli indicating the amount of overlap of the tetramer and dimer fractions on a Superose 6 PC 3.2/30 column. Apparent molecular weights are indicated. Void volume and elution volumes of globular standard proteins with corresponding molecular weights are shown on the x axis. The chromatogram reveals that p63 forms show the same relative elution profiles on a Superose 6 PC 3.2/30 column as on a Superose 6 10/300 GL column (results shown in Figure 5B). Deviations in the predicted masses of the peaks between both columns are due to the lower resolution of the Superose 6 PC 3.2/30 column. (B and C) Bar diagrams showing the intensities of TAp63α (B) and MBP-TAp63γ (C) relative to the respective total intensity for the SEC chromatogram shown in (A). Each value represents a 50 μl fraction between 1.2 and 1.65 ml elution volume. The diagram in (B) displays a maximum at ∼1.55 ml (dimer fraction) and the diagram in (C) at ∼1.35 ml (tetramer fraction) elution volume. The concentration of both proteins was approximately 5 μM. (D) Western blot of 50 μl SEC elution fractions between 1.2 and 1.65 ml of 100 nM MBP-TAp63γ purified from E. coli. (E) Bar diagrams showing the MBP-TAp63γ signal intensities relative to the sum of all intensities of the Western blot in (D). (F and G) Western blot of 50 μl SEC elution fractions between 1.2 and 1.65 ml of 30 nM MBP-TAp63γ (F) and corresponding bar diagram (G).CC BY · PubMed Central
Figure S3 DNA Binding of TAp63 Is Specific, whereas λ-Phosphatase Treatment Leads to Complete Dephosphorylation, Related to Figure 3 (A and B) Binding of MBP-TAp63α (black dots), MBP-TAp63αFTL (red dots), MBP-TAp63γ (blue dots) and MBP-TAp63αR (purple dots) purified from E. coli to 300 nM of SELEX DNA (see Methods section) (A) or to a random sequence (see Methods section) (B) using fluorescence anisotropy. In (A) all TAp63 forms except MBP-TAp63αR bind to the SELEX DNA, with MBP-TAp63αFTL and MBP-TAp63γ showing higher affinity than MBP-TAp63α. In (B) none of the TAp63 forms binds to the random sequence. (C) In vitro phosphorylation assay in which MBP-TAp63α purified from E. coli (lanes 1; 3-8) was incubated in the absence (lane 1) or presence (lanes 2-8) of lysed IRR ovaries (lane 2) for 30 min at RT with 10 μCi [γ-32P]-ATP. The reaction was challenged by 5 U λ-phosphatase (λ-PP) (lane 4), phosphatase inhibitors (Lane 5), 100 μM ATP (lane 6), 100 μM GTP (lane 7) or 100 μM ADP (lane 8). Reactions were stopped by SDS sample buffer and the samples were analyzed on 10% SDS-PAGE. The phosphorylation profile was visualized by autoradiography. (D) Coomassie staining of the gel corresponding to (C) showing MBP-TAp63α as loading control.
Figure S3 DNA Binding of TAp63 Is Specific, whereas λ-Phosphatase Treatment Leads to Complete Dephosphorylation, Related to Figure 3 (A and B) Binding of MBP-TAp63α (black dots), MBP-TAp63αFTL (red dots), MBP-TAp63γ (blue dots) and MBP-TAp63αR (purple dots) purified from E. coli to 300 nM of SELEX DNA (see Methods section) (A) or to a random sequence (see Methods section) (B) using fluorescence anisotropy. In (A) all TAp63 forms except MBP-TAp63αR bind to the SELEX DNA, with MBP-TAp63αFTL and MBP-TAp63γ showing higher affinity than MBP-TAp63α. In (B) none of the TAp63 forms binds to the random sequence. (C) In vitro phosphorylation assay in which MBP-TAp63α purified from E. coli (lanes 1; 3-8) was incubated in the absence (lane 1) or presence (lanes 2-8) of lysed IRR ovaries (lane 2) for 30 min at RT with 10 μCi [γ-32P]-ATP. The reaction was challenged by 5 U λ-phosphatase (λ-PP) (lane 4), phosphatase inhibitors (Lane 5), 100 μM ATP (lane 6), 100 μM GTP (lane 7) or 100 μM ADP (lane 8). Reactions were stopped by SDS sample buffer and the samples were analyzed on 10% SDS-PAGE. The phosphorylation profile was visualized by autoradiography. (D) Coomassie staining of the gel corresponding to (C) showing MBP-TAp63α as loading control.CC BY · PubMed Central
Figure S4 The Second Helix H2 in the TD Is Essential for the Formation of Stable Tetramers, Related to Figure 4 Transcriptional activities on the p21 promoter in SAOS2 cells of TAp63γ, TAp63α, TAp63α without Helix H2 (TAp63αΔHelix), TAp63αFTL and TAp63αFTL without Helix H2 (TAp63αFTLΔHelix) with the activity of TAp63γ set to 100%. Experiments were performed in triplicate. Error bars show standard deviation.
Figure S4 The Second Helix H2 in the TD Is Essential for the Formation of Stable Tetramers, Related to Figure 4 Transcriptional activities on the p21 promoter in SAOS2 cells of TAp63γ, TAp63α, TAp63α without Helix H2 (TAp63αΔHelix), TAp63αFTL and TAp63αFTL without Helix H2 (TAp63αFTLΔHelix) with the activity of TAp63γ set to 100%. Experiments were performed in triplicate. Error bars show standard deviation.CC BY · PubMed Central
Figure S5 SEC Analysis of Mutations in the Tetramerization Interface of the TD of TAp63α, Related to Figure 5 (A and B) Western blot analysis of SEC elution fractions from 1.04 to 1.69 ml of TAp63αMI expressed in rabbit reticulocyte lysate using an anti-myc antibody (A) and bar diagram of the Western blot intensities (B). (C–F) Corresponding data and analysis of TAp63αL and TAp63αLM are shown in (C and D) and (E and F), respectively. The introduction of the M374Q/I378R dimer mutation in the center of the tetramerization interface of TAp63αMI leads to the destabilization of the inhibitory TA-TID interaction. This results in a dimeric protein with a more opened conformation in which both the TA domain and the TID are at least partially accessible for interactions with the corresponding external interaction partner in pull-down assays. Mutations introduced at the edges of the tetramerization interface (TAp63αLM and TAp63αL) do not affect the interaction between TID and TA domain suggesting the involvement of specific areas of the TD in the inhibitory mechanism mediated by the TID.
Figure S5 SEC Analysis of Mutations in the Tetramerization Interface of the TD of TAp63α, Related to Figure 5 (A and B) Western blot analysis of SEC elution fractions from 1.04 to 1.69 ml of TAp63αMI expressed in rabbit reticulocyte lysate using an anti-myc antibody (A) and bar diagram of the Western blot intensities (B). (C–F) Corresponding data and analysis of TAp63αL and TAp63αLM are shown in (C and D) and (E and F), respectively. The introduction of the M374Q/I378R dimer mutation in the center of the tetramerization interface of TAp63αMI leads to the destabilization of the inhibitory TA-TID interaction. This results in a dimeric protein with a more opened conformation in which both the TA domain and the TID are at least partially accessible for interactions with the corresponding external interaction partner in pull-down assays. Mutations introduced at the edges of the tetramerization interface (TAp63αLM and TAp63αL) do not affect the interaction between TID and TA domain suggesting the involvement of specific areas of the TD in the inhibitory mechanism mediated by the TID.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Brandt, 2009, Conservation of DNA-binding specificity and oligomerisation properties within the p53 family, BMC Genomics, 10, 628, 10.1186/1471-2164-10-628 · DOI · Paper page
  2. Burge, 2009, Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation, Proc. Natl. Acad. Sci. USA, 106, 3142, 10.1073/pnas.0900383106 · DOI
  3. Celli, 1999, Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome, Cell, 99, 143, 10.1016/S0092-8674(00)81646-3 · DOI · Paper page
  4. Chan, 2004, How many mutant p53 molecules are needed to inactivate a tetramer?, Mol. Cell. Biol., 24, 3536, 10.1128/MCB.24.8.3536-3551.2004 · DOI · Paper page
  5. Chene, 2001, The role of tetramerization in p53 function, Oncogene, 20, 2611, 10.1038/sj.onc.1204373 · DOI · Paper page
  6. Cole, 2004, Analysis of heterogeneous interactions, Methods Enzymol., 384, 212, 10.1016/S0076-6879(04)84013-8 · DOI
  7. Coutandin, 2009, Conformational stability and activity of p73 require a second helix in the tetramerization domain, Cell Death Differ., 16, 1582, 10.1038/cdd.2009.139 · DOI
  8. Coutandin, 2010, Tracing the protectors path from the germ line to the genome, Proc. Natl. Acad. Sci. USA, 107, 15318, 10.1073/pnas.1001069107 · DOI
  9. Davison, 2001, Structure and functionality of a designed p53 dimer, J. Mol. Biol., 307, 605, 10.1006/jmbi.2001.4450 · DOI
  10. De Laurenzi, 1999, Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta, Cell Death Differ., 6, 389, 10.1038/sj.cdd.4400521 · DOI
  11. Derry, 2001, Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance, Science, 294, 591, 10.1126/science.1065486 · DOI · Paper page
  12. Guo, 2009, TAp63 induces senescence and suppresses tumorigenesis in vivo, Nat. Cell Biol., 11, 1451, 10.1038/ncb1988 · DOI · Paper page
  13. Hoffmann, 2009, Probing the limits of liquid droplet laser desorption mass spectrometry in the analysis of oligonucleotides and nucleic acids, Rapid Commun. Mass Spectrom., 23, 2176, 10.1002/rcm.4129 · doi:10.1002/rcm.4129
  14. Horikoshi, 1995, Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression, Mol. Cell. Biol., 15, 227, 10.1128/MCB.15.1.227 · DOI · Paper page
  15. Jeffrey, 1995, Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms, Science, 267, 1498, 10.1126/science.7878469 · DOI · Paper page
  16. Joerger, 2009, Structural evolution of p53, p63, and p73: implication for heterotetramer formation, Proc. Natl. Acad. Sci. USA, 106, 17705, 10.1073/pnas.0905867106 · DOI
  17. Kaghad, 1997, Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers, Cell, 90, 809, 10.1016/S0092-8674(00)80540-1 · DOI · Paper page
  18. Lebowitz, 2002, Modern analytical ultracentrifugation in protein science: a tutorial review, Protein Sci., 11, 2067, 10.1110/ps.0207702 · DOI · Paper page
  19. Lee, 1994, Solution structure of the tetrameric minimum transforming domain of p53, Nat. Struct. Biol., 1, 877, 10.1038/nsb1294-877 · DOI · Paper page
  20. Lu, 1995, Human TAFII31 protein is a transcriptional coactivator of the p53 protein, Proc. Natl. Acad. Sci. USA, 92, 5154, 10.1073/pnas.92.11.5154 · DOI · Paper page
  21. McGrath, 2001, Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63, Hum. Mol. Genet., 10, 221, 10.1093/hmg/10.3.221 · DOI · Paper page
  22. Mills, 1999, p63 is a p53 homologue required for limb and epidermal morphogenesis, Nature, 398, 708, 10.1038/19531 · DOI · Paper page
  23. Morgner, 2007, A novel approach to analyze membrane proteins by laser mass spectrometry: from protein subunits to the integral complex, J. Am. Soc. Mass Spectrom., 18, 1429, 10.1016/j.jasms.2007.04.013 · DOI
  24. Ortt, 2006, Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53, FEBS Lett., 580, 4544, 10.1016/j.febslet.2006.07.004 · DOI
  25. Ou, 2007, Structural evolution of C-terminal domains in the p53 family, EMBO J., 26, 3463, 10.1038/sj.emboj.7601764 · DOI
  26. Pearson, 2010, A planarian p53 homolog regulates proliferation and self-renewal in adult stem cell lineages, Development, 137, 213, 10.1242/dev.044297 · DOI · Paper page
  27. Rossi, 2006, The E3 ubiquitin ligase Itch controls the protein stability of p63, Proc. Natl. Acad. Sci. USA, 103, 12753, 10.1073/pnas.0603449103 · DOI · Paper page
  28. Schleiff, 2003, A GTP-driven motor moves proteins across the outer envelope of chloroplasts, Proc. Natl. Acad. Sci. USA, 100, 4604, 10.1073/pnas.0730860100 · DOI
  29. Schmale, 1997, A novel protein with strong homology to the tumor suppressor p53, Oncogene, 15, 1363, 10.1038/sj.onc.1201500 · DOI · Paper page
  30. Senoo, 1998, A second p53-related protein, p73L, with high homology to p73, Biochem. Biophys. Res. Commun., 248, 603, 10.1006/bbrc.1998.9013 · DOI
  31. Serber, 2002, A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism, Mol. Cell. Biol., 22, 8601, 10.1128/MCB.22.24.8601-8611.2002 · DOI · Paper page
  32. Straub, 2010, The C-terminus of p63 contains multiple regulatory elements with different functions, Cell Death Dis., 1, e5, 10.1038/cddis.2009.1 · DOI
  33. Suh, 2006, p63 protects the female germ line during meiotic arrest, Nature, 444, 624, 10.1038/nature05337 · DOI · Paper page
  34. Thut, 1995, p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60, Science, 267, 100, 10.1126/science.7809597 · DOI · Paper page
  35. Trink, 1998, A new human p53 homologue, Nat. Med., 4, 747, 10.1038/nm0798-747 · DOI · Paper page
  36. Yang, 1998, p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities, Mol. Cell, 2, 305, 10.1016/S1097-2765(00)80275-0 · DOI · Paper page
  37. Yang, 1999, p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development, Nature, 398, 714, 10.1038/19539 · DOI · Paper page
  38. Yang, 2000, p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours, Nature, 404, 99, 10.1038/35003607 · DOI · Paper page
  39. Ying, 2005, DNA-binding and transactivation activities are essential for TAp63 protein degradation, Mol. Cell. Biol., 25, 6154, 10.1128/MCB.25.14.6154-6164.2005 · DOI

Cited by

See all 131

Metadata

Authors
Deutsch, G. B., Zielonka, E. M., Coutandin, D., Weber, T. A., Schäfer, B., Hannewald, J., Luh, L. M., Durst, F. G., Ibrahim, M., Hoffmann, J., Niesen, F. H., Sentürk, A., Kunkel, H., Brutschy, B., Schleiff, E., Knapp, S., Acker-Palmer, A., Grez, M., McKeon, F., & Dötsch, V.
Venue
Cell
Publisher
Elsevier BV
Published
2011-02
Volume
144
Issue
4
Pages
566-576
ISSN
0092-8674
Cited by
131
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.